{"id":"https://openalex.org/W1968217355","doi":"https://doi.org/10.1046/j.1528-1157.2001.36500.x","title":"Tiagabine: Efficacy and Safety in Adjunctive Treatment of Partial Seizures","display_name":"Tiagabine: Efficacy and Safety in Adjunctive Treatment of Partial Seizures","publication_year":2001,"publication_date":"2001-04-20","ids":{"openalex":"https://openalex.org/W1968217355","doi":"https://doi.org/10.1046/j.1528-1157.2001.36500.x","mag":"1968217355","pmid":"https://pubmed.ncbi.nlm.nih.gov/11440349"},"language":"en","primary_location":{"id":"doi:10.1046/j.1528-1157.2001.36500.x","doi":"https://doi.org/10.1046/j.1528-1157.2001.36500.x","is_oa":false,"landing_page_url":"https://doi.org/10.1046/j.1528-1157.2001.36500.x","pdf_url":null,"source":{"id":"https://openalex.org/S203153751","display_name":"Epilepsia","issn_l":"0013-9580","issn":["0013-9580","1528-1157","1528-1167"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Epilepsia","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5072105742","display_name":"Pamela M Crawford","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"P. Crawford","raw_affiliation_strings":["Bootham Park Hospital, York, England"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Bootham Park Hospital, York, England","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5041672590","display_name":"H. Meinardi","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210161862","display_name":"Stichting Epilepsie Instellingen Nederland","ror":"https://ror.org/051ae7717","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I4210161862"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"H. Meinardi","raw_affiliation_strings":["Instituut voor Epilepsiebestrijding, Heemstede, The Netherlands;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Instituut voor Epilepsiebestrijding, Heemstede, The Netherlands;","institution_ids":["https://openalex.org/I4210161862"]}]},{"author_position":"middle","author":{"id":null,"display_name":"S. Brown","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"S. Brown","raw_affiliation_strings":["The David Lewis Centre for Epilepsy, Warford, Cheshire, England;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The David Lewis Centre for Epilepsy, Warford, Cheshire, England;","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5069396241","display_name":"Th.W. Rentmeester","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210132398","display_name":"Kempenhaeghe","ror":"https://ror.org/03bbe8e53","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I4210132398"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"TH. W. Rentmeester","raw_affiliation_strings":["Epilepsiecentrum Kempenhaeghe, Heeze, The Netherlands;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Epilepsiecentrum Kempenhaeghe, Heeze, The Netherlands;","institution_ids":["https://openalex.org/I4210132398"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112454013","display_name":"B. Pedersen","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2799976261","display_name":"Aalborg University Hospital","ror":"https://ror.org/02jk5qe80","country_code":"DK","type":"healthcare","lineage":["https://openalex.org/I2799976261"]}],"countries":["DK"],"is_corresponding":false,"raw_author_name":"B. Pedersen","raw_affiliation_strings":["A\u030alborg Hospital, A\u030alborg; and","\u00c5lborg Hospital, \u00c5lborg; and"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"A\u030alborg Hospital, A\u030alborg; and","institution_ids":["https://openalex.org/I2799976261"]},{"raw_affiliation_string":"\u00c5lborg Hospital, \u00c5lborg; and","institution_ids":["https://openalex.org/I2799976261"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111728639","display_name":"P. C. Pedersen","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I189090001","display_name":"Novo Nordisk (Denmark)","ror":"https://ror.org/0435rc536","country_code":"DK","type":"company","lineage":["https://openalex.org/I189090001","https://openalex.org/I2801134892","https://openalex.org/I4210159963"]}],"countries":["DK"],"is_corresponding":false,"raw_author_name":"P. C. Pedersen","raw_affiliation_strings":["Novo Nordisk A/S, Copenhagen, Denmark"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Novo Nordisk A/S, Copenhagen, Denmark","institution_ids":["https://openalex.org/I189090001"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5075657988","display_name":"Lars Christian Lassen","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I189090001","display_name":"Novo Nordisk (Denmark)","ror":"https://ror.org/0435rc536","country_code":"DK","type":"company","lineage":["https://openalex.org/I189090001","https://openalex.org/I2801134892","https://openalex.org/I4210159963"]}],"countries":["DK"],"is_corresponding":false,"raw_author_name":"L. C. Lassen","raw_affiliation_strings":["Novo Nordisk A/S, Copenhagen, Denmark"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Novo Nordisk A/S, Copenhagen, Denmark","institution_ids":["https://openalex.org/I189090001"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":4,"corresponding_author_ids":["https://openalex.org/A5072105742"],"corresponding_institution_ids":[],"apc_list":{"value":4360,"currency":"USD","value_usd":4360},"apc_paid":null,"fwci":1.5687,"has_fulltext":false,"cited_by_count":32,"citation_normalized_percentile":{"value":0.81571383,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":87,"max":97},"biblio":{"volume":"42","issue":"4","first_page":"531","last_page":"538"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10094","display_name":"Epilepsy research and treatment","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10094","display_name":"Epilepsy research and treatment","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12229","display_name":"Pharmacological Effects and Toxicity Studies","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2735","display_name":"Pediatrics, Perinatology and Child Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12267","display_name":"Diet and metabolism studies","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2737","display_name":"Physiology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/tiagabine","display_name":"tiagabine","score":1.0},{"id":"https://openalex.org/keywords/focal-seizures","display_name":"focal seizures","score":0.8550000190734863},{"id":"https://openalex.org/keywords/drug-resistant-epilepsy","display_name":"drug-resistant epilepsy","score":0.7960000038146973},{"id":"https://openalex.org/keywords/adjunctive-antiepileptic-therapy","display_name":"adjunctive antiepileptic therapy","score":0.9390000104904175},{"id":"https://openalex.org/keywords/complex-partial-seizures","display_name":"complex partial seizures","score":0.8859999775886536},{"id":"https://openalex.org/keywords/secondarily-generalized-tonic-clonic-seizures","display_name":"secondarily generalized tonic-clonic seizures","score":0.9020000100135803},{"id":"https://openalex.org/keywords/drug-safety","display_name":"drug safety","score":0.6420000195503235},{"id":"https://openalex.org/keywords/adverse-events","display_name":"adverse events","score":0.906000018119812},{"id":"https://openalex.org/keywords/drug-interactions","display_name":"drug interactions","score":0.48899999260902405},{"id":"https://openalex.org/keywords/plasma-drug-concentration","display_name":"plasma drug concentration","score":0.5099999904632568}],"concepts":[{"id":"https://openalex.org/C2776749334","wikidata":"https://www.wikidata.org/wiki/Q907219","display_name":"Tiagabine","level":4,"score":0.7191751003265381},{"id":"https://openalex.org/C87813604","wikidata":"https://www.wikidata.org/wiki/Q1242899","display_name":"Crossover study","level":4,"score":0.7159174680709839},{"id":"https://openalex.org/C27081682","wikidata":"https://www.wikidata.org/wiki/Q269829","display_name":"Placebo","level":3,"score":0.7072139382362366},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6766905784606934},{"id":"https://openalex.org/C204243189","wikidata":"https://www.wikidata.org/wiki/Q1363085","display_name":"Randomization","level":3,"score":0.6594126224517822},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.6190093755722046},{"id":"https://openalex.org/C42219234","wikidata":"https://www.wikidata.org/wiki/Q131130","display_name":"Anesthesia","level":1,"score":0.563718318939209},{"id":"https://openalex.org/C2777803345","wikidata":"https://www.wikidata.org/wiki/Q7140388","display_name":"partial seizures","level":3,"score":0.5594562292098999},{"id":"https://openalex.org/C2778186239","wikidata":"https://www.wikidata.org/wiki/Q41571","display_name":"Epilepsy","level":2,"score":0.5523051023483276},{"id":"https://openalex.org/C3018162438","wikidata":"https://www.wikidata.org/wiki/Q1304270","display_name":"Adjunctive treatment","level":2,"score":0.48291727900505066},{"id":"https://openalex.org/C2775858608","wikidata":"https://www.wikidata.org/wiki/Q576618","display_name":"Anticonvulsant","level":3,"score":0.4782249629497528},{"id":"https://openalex.org/C2991744798","wikidata":"https://www.wikidata.org/wiki/Q608510","display_name":"Double blind","level":4,"score":0.46741983294487},{"id":"https://openalex.org/C58732023","wikidata":"https://www.wikidata.org/wiki/Q770260","display_name":"Partial agonist","level":4,"score":0.4530356824398041},{"id":"https://openalex.org/C2778375690","wikidata":"https://www.wikidata.org/wiki/Q7814214","display_name":"Tolerability","level":3,"score":0.4110400080680847},{"id":"https://openalex.org/C168563851","wikidata":"https://www.wikidata.org/wiki/Q1436668","display_name":"Randomized controlled trial","level":2,"score":0.3561900854110718},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.32626956701278687},{"id":"https://openalex.org/C2778938600","wikidata":"https://www.wikidata.org/wiki/Q389934","display_name":"Agonist","level":3,"score":0.10093516111373901},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.0},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.0},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.0},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000078308","descriptor_name":"Tiagabine","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000293","descriptor_name":"Adolescent","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000927","descriptor_name":"Anticonvulsants","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D000927","descriptor_name":"Anticonvulsants","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D000927","descriptor_name":"Anticonvulsants","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D001007","descriptor_name":"Anxiety","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":false},{"descriptor_ui":"D001247","descriptor_name":"Asthenia","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":false},{"descriptor_ui":"D004244","descriptor_name":"Dizziness","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":false},{"descriptor_ui":"D004311","descriptor_name":"Double-Blind Method","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004334","descriptor_name":"Drug Administration Schedule","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004359","descriptor_name":"Drug Therapy, Combination","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004828","descriptor_name":"Epilepsies, Partial","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006261","descriptor_name":"Headache","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009557","descriptor_name":"Nipecotic Acids","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D009557","descriptor_name":"Nipecotic Acids","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D009557","descriptor_name":"Nipecotic Acids","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D010349","descriptor_name":"Patient Compliance","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010352","descriptor_name":"Patient Dropouts","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010919","descriptor_name":"Placebos","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018592","descriptor_name":"Cross-Over Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1046/j.1528-1157.2001.36500.x","doi":"https://doi.org/10.1046/j.1528-1157.2001.36500.x","is_oa":false,"landing_page_url":"https://doi.org/10.1046/j.1528-1157.2001.36500.x","pdf_url":null,"source":{"id":"https://openalex.org/S203153751","display_name":"Epilepsia","issn_l":"0013-9580","issn":["0013-9580","1528-1157","1528-1167"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Epilepsia","raw_type":"journal-article"},{"id":"pmid:11440349","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/11440349","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Epilepsia","raw_type":"Clinical Trial"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":1.0,"display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/clinical-trial","display_name":"Clinical Trial"}],"awards":[],"funders":[{"id":"https://openalex.org/F4320321390","display_name":"Fonds De La Recherche Scientifique - FNRS","ror":"https://ror.org/03q83t159"}],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":23,"referenced_works":["https://openalex.org/W1969836247","https://openalex.org/W1971616238","https://openalex.org/W2002729353","https://openalex.org/W2007580188","https://openalex.org/W2019329926","https://openalex.org/W2021334241","https://openalex.org/W2028900097","https://openalex.org/W2045466500","https://openalex.org/W2048791185","https://openalex.org/W2051154442","https://openalex.org/W2054779080","https://openalex.org/W2092254107","https://openalex.org/W2092571805","https://openalex.org/W2130944577","https://openalex.org/W2138240764","https://openalex.org/W2157771225","https://openalex.org/W2165891764","https://openalex.org/W2322849220","https://openalex.org/W2400896564","https://openalex.org/W3031773612","https://openalex.org/W3036423487","https://openalex.org/W4251662319","https://openalex.org/W4285719527"],"related_works":["https://openalex.org/W2065174084","https://openalex.org/W2110167505","https://openalex.org/W2092254107","https://openalex.org/W1979402597","https://openalex.org/W1968465698","https://openalex.org/W2170734360","https://openalex.org/W179835007","https://openalex.org/W1876312579","https://openalex.org/W2096201943","https://openalex.org/W2411401905"],"abstract_inverted_index":{"PURPOSE:":[0],"To":[1],"assess":[2],"the":[3,98,117,122,126,169,180,192,201],"efficacy":[4],"and":[5,65,148,189,213,242],"safety":[6],"of":[7,116,125,159,164,186,205,225,238],"tiagabine":[8],"(TGB),":[9],"a":[10,49,109,162],"new":[11],"antiepileptic":[12],"drug":[13],"(AED),":[14],"as":[15],"add-on":[16],"therapy":[17],"in":[18,86,137,168,236,246],"patients":[19,35,120,160,176,196,247],"with":[20,135,211,217,248],"refractory":[21],"partial":[22,70,139,144,171],"seizures.":[23,252],"METHODS:":[24],"This":[25],"response-dependent":[26],"study":[27,127],"used":[28],"an":[29,73],"open-label":[30],"screening":[31],"phase":[32,124,182,203],"(in":[33],"which":[34,101,129,187],"were":[36,93,131,191],"titrated":[37],"to":[38,91,250],"their":[39],"optimal":[40],"TGB":[41,81,178,212,219,230],"dose,":[42],"<":[43,141,146,155],"or":[44,68,83,166],"=64":[45],"mg/day)":[46],"followed":[47],"by":[48,62,108],"double-blind,":[50],"placebo-controlled,":[51],"crossover":[52,111],"phase.":[53],"Initial":[54],"eligibility":[55],"criteria":[56],"included":[57],"(a)":[58],"seizures":[59,71],"inadequately":[60],"controlled":[61],"existing":[63],"AEDs,":[64],"(b)":[66],"six":[67],"more":[69],"during":[72,128,179,200,209,215],"8-week":[74],"baseline":[75],"period.":[76,112],"Patients":[77],"showing":[78],"benefit":[79],"from":[80,198],"(>":[82],"=25%":[84],"reduction":[85,163,241],"total":[87],"seizure":[88,152,172,239],"rate":[89,240],"relative":[90],"baseline)":[92],"eligible":[94],"for":[95],"randomization":[96],"into":[97],"double-blind":[99,123,181,202],"phase,":[100],"comprised":[102],"two":[103,208],"7-week":[104],"assessment":[105],"periods":[106],"separated":[107],"3-week":[110],"RESULTS:":[113],"Forty-four":[114],"(50%)":[115],"88":[118],"enrolled":[119],"entered":[121],"there":[130],"significant":[132],"reductions":[133],"compared":[134],"placebo":[136,235],"all":[138,170],"(p":[140,145,154],"0.01),":[142],"complex":[143],"0.001),":[147],"secondarily":[149],"generalized":[150],"tonic-clonic":[151],"rates":[153],"0.05).":[156],"Thirty-three":[157],"percent":[158],"experienced":[161],">":[165],"=50%":[167],"rate.":[173],"Eight":[174],"(22%)":[175],"receiving":[177],"reported":[183],"adverse":[184,206],"events,":[185],"dizziness":[188],"incoordination":[190],"most":[193],"frequent.":[194],"Three":[195],"withdrew":[197],"treatment":[199,210,216],"because":[204],"events;":[207],"one":[214],"placebo.":[218],"did":[220],"not":[221],"affect":[222],"plasma":[223],"concentrations":[224],"other":[226],"coadministered":[227],"AEDs.":[228],"CONCLUSIONS:":[229],"was":[231,243],"significantly":[232],"better":[233],"than":[234],"terms":[237],"generally":[244],"well-tolerated":[245],"difficult":[249],"control":[251]},"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":1},{"year":2019,"cited_by_count":1},{"year":2018,"cited_by_count":1},{"year":2016,"cited_by_count":2},{"year":2015,"cited_by_count":1},{"year":2014,"cited_by_count":3},{"year":2012,"cited_by_count":4}],"updated_date":"2026-11-07T11:25:07.637180","created_date":"2016-06-24T00:00:00"}